Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Moore

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Research Square|December 4, 2023
A Whole Food, Plant-Based Randomized Controlled Trial in Metastatic Breast Cancer: Feasibility, Nutrient, and Patient-Reported OutcomesErin K Campbell, Thomas M Campbell, Eva Culakova, et al.
Gynecologic Oncology|August 20, 2013
A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancerThomas Rutherford, James Orr, Edward Grendys, et al.
Scientific Reports|January 7, 2014
HE4 (WFDC2) gene overexpression promotes ovarian tumor growthRichard G Moore, Emily K Hill, Timothy Horan, et al.
Research Square|November 21, 2023
A Whole-Food, Plant-Based Randomized Controlled Trial in Metastatic Breast Cancer: Weight, Cardiometabolic, and Hormonal OutcomeThomas M Campbell, Erin K Campbell, Eva Culakova, et al.
Breast Cancer Research and Treatment|March 30, 2024
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomesErin K Campbell, Thomas M Campbell, Eva Culakova, et al.
Journal of the National Cancer Institute|June 20, 2015
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 TrialAshley S Felix, Louise A Brinton, D Scott McMeekin, et al.
Breast Cancer Research and Treatment|March 6, 2024
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomesThomas M Campbell, Erin K Campbell, Eva Culakova, et al.
Gynecologic Oncology|March 15, 2013
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trialLouise A Brinton, Ashley S Felix, D Scott McMeekin, et al.
Gynecologic Oncology|July 2, 2025
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIOMelissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Frontiers in Pharmacology|April 4, 2019
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6Nicole E James, Matthew T Oliver, Jennifer R Ribeiro, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Research Square|December 4, 2023
A Whole Food, Plant-Based Randomized Controlled Trial in Metastatic Breast Cancer: Feasibility, Nutrient, and Patient-Reported OutcomesErin K Campbell, Thomas M Campbell, Eva Culakova, et al.
Gynecologic Oncology|August 20, 2013
A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancerThomas Rutherford, James Orr, Edward Grendys, et al.
Scientific Reports|January 7, 2014
HE4 (WFDC2) gene overexpression promotes ovarian tumor growthRichard G Moore, Emily K Hill, Timothy Horan, et al.
Research Square|November 21, 2023
A Whole-Food, Plant-Based Randomized Controlled Trial in Metastatic Breast Cancer: Weight, Cardiometabolic, and Hormonal OutcomeThomas M Campbell, Erin K Campbell, Eva Culakova, et al.
Breast Cancer Research and Treatment|March 30, 2024
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomesErin K Campbell, Thomas M Campbell, Eva Culakova, et al.
Journal of the National Cancer Institute|June 20, 2015
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 TrialAshley S Felix, Louise A Brinton, D Scott McMeekin, et al.
Breast Cancer Research and Treatment|March 6, 2024
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomesThomas M Campbell, Erin K Campbell, Eva Culakova, et al.
Gynecologic Oncology|March 15, 2013
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trialLouise A Brinton, Ashley S Felix, D Scott McMeekin, et al.
Gynecologic Oncology|July 2, 2025
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIOMelissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Frontiers in Pharmacology|April 4, 2019
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6Nicole E James, Matthew T Oliver, Jennifer R Ribeiro, et al.
Pageof 12